Direct Biologics, LLC Announces One Year Follow Up of Pilot Safety Study of ExoFlo for Treatment of Osteoarthritis in Combat-Related Injuries
11 nov. 2021 14h11 HE
|
Direct Biologics
AUSTIN, Texas, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Direct Biologics, LLC, a market-leading biotech company in the field of regenerative biologics, announced the publication of the one-year follow-up...